Terms: = Ovarian cancer AND DDB2, Q92466, 1643, ENSG00000134574, FLJ34321 AND Treatment
5 results:
1. ddb2 represses ovarian cancer cell dedifferentiation by suppressing ALDH1A1.
Cui T; Srivastava AK; Han C; Wu D; Wani N; Liu L; Gao Z; Qu M; Zou N; Zhang X; Yi P; Yu J; Bell EH; Yang SM; Maloney DJ; Zheng Y; Wani AA; Wang QE
Cell Death Dis; 2018 May; 9(5):561. PubMed ID: 29752431
[TBL] [Abstract] [Full Text] [Related]
2. ddb2 modulates TGF-β signal transduction in human ovarian cancer cells by downregulating NEDD4L.
Zhao R; Cui T; Han C; Zhang X; He J; Srivastava AK; Yu J; Wani AA; Wang QE
Nucleic Acids Res; 2015 Sep; 43(16):7838-49. PubMed ID: 26130719
[TBL] [Abstract] [Full Text] [Related]
3. DNA damage-binding complex recruits HDAC1 to repress Bcl-2 transcription in human ovarian cancer cells.
Zhao R; Han C; Eisenhauer E; Kroger J; Zhao W; Yu J; Selvendiran K; Liu X; Wani AA; Wang QE
Mol Cancer Res; 2014 Mar; 12(3):370-80. PubMed ID: 24249678
[TBL] [Abstract] [Full Text] [Related]
4. Overexpression of ddb2 enhances the sensitivity of human ovarian cancer cells to cisplatin by augmenting cellular apoptosis.
Barakat BM; Wang QE; Han C; Milum K; Yin DT; Zhao Q; Wani G; Arafa el-SA; El-Mahdy MA; Wani AA
Int J Cancer; 2010 Aug; 127(4):977-88. PubMed ID: 20013802
[TBL] [Abstract] [Full Text] [Related]
5. Incidence and management of pancreatic leaks after splenectomy with distal pancreatectomy performed during primary cytoreductive surgery for advanced ovarian, peritoneal and fallopian tube cancer.
Kehoe SM; Eisenhauer EL; Abu-Rustum NR; Sonoda Y; D'Angelica M; Jarnagin WR; Barakat RR; Chi DS
Gynecol Oncol; 2009 Mar; 112(3):496-500. PubMed ID: 19091388
[TBL] [Abstract] [Full Text] [Related]
